AVITA Medical, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
AVITA Medical, Inc. (RCEL) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period of 109.18 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod · last filed 2026-02-12
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2025-09-30 was 32.46K shares, a 61.30% decline year-over-year.
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2025-06-30 was 62.12K shares.
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2025-03-31 was 14.61K shares.
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2025 was 109.18K shares, a 26.49% decline from fiscal 2024.
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2024 was 148.53K shares, a 36.81% decline from fiscal 2023.
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2023 was 235.06K shares, a 77.31% increase from fiscal 2022.
- AVITA Medical, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2022 was 132.57K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | 32.46K shares derived: sum of 2 quarters · filed 2026-02-12 | 94.57K shares derived: sum of 3 quarters · filed 2026-02-12 | 109.18K shares 10-K · filed 2026-02-12 |
| 2025-09-30 | 32.46K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 94.57K shares derived: sum of 2 quarters · filed 2025-11-06 | 109.18K shares 10-Q · filed 2025-11-06 | 119.94K shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 62.12K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | 76.72K shares 10-Q · filed 2025-08-08 | 87.48K shares derived: sum of 3 quarters · filed 2025-08-08 | 171.34K shares derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | 14.61K shares 10-Q · filed 2025-05-08 | 25.37K shares derived: sum of 2 quarters · filed 2025-05-08 | 109.22K shares derived: sum of 3 quarters · filed 2025-05-08 | |
| 2024-12-31 | 10.76K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | 94.61K shares derived: sum of 2 quarters · filed 2025-02-13 | 148.53K shares 10-K · filed 2025-02-13 | |
| 2024-09-30 | 83.86K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 137.77K shares 10-Q · filed 2024-11-07 | ||
| 2024-06-30 | 53.92K shares 10-Q · filed 2024-08-08 | |||
| 2023-12-31 | 56.55K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 142.41K shares derived: sum of 2 quarters · filed 2024-02-22 | 147.41K shares derived: sum of 3 quarters · filed 2024-02-22 | 235.06K shares 10-K · filed 2024-02-22 |
| 2023-09-30 | 85.86K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 90.86K shares derived: sum of 2 quarters · filed 2023-11-09 | 178.51K shares 10-Q · filed 2023-11-09 | 206.04K shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 5.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 92.65K shares 10-Q · filed 2023-08-10 | 120.18K shares derived: sum of 3 quarters · filed 2023-08-10 | 148.00K shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | 87.65K shares 10-Q · filed 2023-05-11 | 115.18K shares derived: sum of 2 quarters · filed 2023-05-11 | 143.00K shares derived: sum of 3 quarters · filed 2023-05-11 | 190.50K shares derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | 27.53K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 55.35K shares derived: sum of 2 quarters · filed 2023-02-23 | 102.86K shares derived: sum of 3 quarters · filed 2023-02-23 | 132.57K shares 10-K · filed 2023-02-23 |
| 2022-09-30 | 27.81K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 75.32K shares derived: sum of 2 quarters · filed 2022-11-10 | 105.03K shares 10-Q · filed 2022-11-10 | 105.03K shares derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | 47.51K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 77.22K shares 10-Q · filed 2022-08-11 | 77.22K shares derived: sum of 3 quarters · filed 2022-08-11 | 105.97K shares derived: sum of 4 quarters · filed 2022-08-11 |
| 2022-03-31 | 29.71K shares 10-Q · filed 2022-05-12 | 29.71K shares derived: sum of 2 quarters · filed 2022-05-12 | 58.47K shares derived: sum of 3 quarters · filed 2022-05-12 | 105.97K shares derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-12-31 | 0.00 shares derived: 10-KT 6 month − 10-Q 3 month · filed 2022-02-28 | 28.75K shares 10-KT · filed 2022-02-28 | 76.26K shares derived: sum of 3 quarters · filed 2022-02-28 | 76.26K shares derived: sum of 4 quarters · filed 2022-02-28 |
| 2021-09-30 | 28.75K shares 10-Q · filed 2021-11-08 | 76.26K shares derived: sum of 2 quarters · filed 2021-11-08 | 76.26K shares derived: sum of 3 quarters · filed 2021-11-08 | 76.26K shares derived: sum of 4 quarters · filed 2021-11-08 |
| 2021-06-30 | 47.51K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-26 | 47.51K shares derived: sum of 2 quarters · filed 2021-08-26 | 47.51K shares derived: sum of 3 quarters · filed 2021-08-26 | 199.34K shares 10-K · filed 2021-08-26 |
| 2021-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | 0.00 shares derived: sum of 2 quarters · filed 2021-05-13 | 151.84K shares 10-Q · filed 2021-05-13 | |
| 2020-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16 | 151.84K shares 10-Q · filed 2021-02-16 | ||
| 2020-09-30 | 151.84K shares 10-Q · filed 2020-11-10 | |||
| 2020-06-30 | 605.18K shares 10-K · filed 2020-08-27 |